Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marie-Josee Masanes"'
Autor:
L. Sese, M. Didier, Christos Chouaid, Perrine Créquit, Marie-Josee Masanes, G. Rousseau-Bussac
Publikováno v:
Revue des Maladies Respiratoires. 32:256-261
RATIONALE Few studies have analyzed the aggressiveness of the care (continuation of active treatments) at the end of life in patients with lung cancer. The objective of this study was to assess practices in this setting in a university department of
Autor:
Christos Chouaid, Sylvie Rostaing-Rigattieri, Bernard Lebeau, Marie-Josee Masanes, Véronique Blanchet
Publikováno v:
Médecine Palliative : Soins de Support - Accompagnement - Éthique. 5:306-317
Resume Rationnel l’indication et les modalites de la sedation en fin de vie sont bien codifiees dans les unites de soins palliatifs mais soulevent des difficultes (souffrance des soignants) dans les services cliniques non specialises en ce domaine.
Publikováno v:
Chest. 107:1365-1369
Objective To learn the value of bronchoscopy and biopsy in the early diagnosis of inhalation injury ARDS. Setting Burn Center, CHU Saint-Antoine, Paris, France. Design 130 consecutively admitted burn patients were bronchoscoped on admission. Measurem
Autor:
Claire Legendre, Dominique Maillard, N. Lioret, Bernard Lebeau, Marie-Josee Masanes, R. Saizy
Publikováno v:
The Journal of Trauma: Injury, Infection, and Critical Care. 36:59-67
The aim of this study was to determine the value of bronchoscopy in the early diagnosis of inhalation injury. A total of 130 burn patients underwent bronchoscopy on admission to a specialized center. In order to validate the method and the bronchosco
Publikováno v:
Lung Cancer
Lung Cancer, 2010, 67 (2), pp.188-93. ⟨10.1016/j.lungcan.2009.03.024⟩
Lung Cancer, Elsevier, 2010, 67 (2), pp.188-93. ⟨10.1016/j.lungcan.2009.03.024⟩
Lung Cancer, 2010, 67 (2), pp.188-93. ⟨10.1016/j.lungcan.2009.03.024⟩
Lung Cancer, Elsevier, 2010, 67 (2), pp.188-93. ⟨10.1016/j.lungcan.2009.03.024⟩
International audience; PURPOSE: There is no standard therapy for progressive or recurrent small cell lung cancer (SCLC). Lomustine, etoposide and cyclophosphamide oral chemotherapy were evaluated in a feasibility study of efficacy survival and toxic
Autor:
Christos Chouaid, M. Didier, Perrine Créquit, L. Sese, Marie-Josee Masanes, G. Rousseau-Bussac
Publikováno v:
Revue des Maladies Respiratoires. 30:A93
Publikováno v:
Revue des Maladies Respiratoires. 23:58